ResMed Inc. RMD
235.30 USD -4.01 (-1.68%)
At closeNov 6, 2026, 6:00 PM EST
235.30 0.00 0.00%
After hours · Nov 6, 6:00 PM ET
231.95 Day range 236.62
180.27 52-week range 277.67
- YTD
- -2.31%
- 1 year
- -5.75%
Analyst view
Consensus: buy
Buy
Price target (mean) 264.33 +12.3% upside
Now 235.30
- Target (low)
- 210.00
- Target (mean)
- 264.33
- Target (high)
- 320.00
Ratings (0m) 20 9 buy · 10 hold · 1 sell
- Strong buy2
- Buy7
- Hold10
- Sell1
- Strong sell0
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 20
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.99 | 2.93 – 3.13 | 2.81 | +6.4% | 1.46B | +2.4% | 13 |
| Next quarter | 3.06 | 3.02 – 3.10 | 2.86 | +6.9% | 1.46B | +1.8% | 13 |
| Current year | 12.14 | 12.02 – 12.23 | 11.17 | +8.7% | 5.84B | +3.2% | 21 |
| Next year | 13.23 | 12.71 – 13.73 | 12.14 | +8.9% | 6.21B | +6.4% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Canaccord Genuity | Downgrade | Buy | Hold |
| Oct 30, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Oct 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Oct 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Sep 15, 2026 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Aug 31, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 19, 2026 | Rothschild & Co | Initiated | — | Neutral |
| Aug 7, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Aug 7, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Aug 7, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 15, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 13, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Jul 10, 2026 | Jefferies | Maintained | Hold | Hold |
| Jul 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 8, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jun 22, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jun 17, 2026 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Jun 15, 2026 | Citigroup | Maintained | Buy | Buy |
| May 1, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Apr 27, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Apr 9, 2026 | Citigroup | Maintained | Buy | Buy |
| Feb 2, 2026 | Citigroup | Maintained | Buy | Buy |
| Jan 30, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jan 30, 2026 | Piper Sandler | Maintained | Neutral | Neutral |
| Jan 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jan 30, 2026 | Stifel | Maintained | Hold | Hold |
| Dec 18, 2025 | Stifel | Maintained | Hold | Hold |
